Copyright: ©Author(s) 2026.
World J Gastroenterol. May 21, 2026; 32(19): 115332
Published online May 21, 2026. doi: 10.3748/wjg.v32.i19.115332
Published online May 21, 2026. doi: 10.3748/wjg.v32.i19.115332
Figure 7 The mechanism of PRMT5 promoting malignant growth of hepatocellular carcinoma via anti-apoptosis.
HCC: Hepatocellular carcinoma.
- Citation: Jiang H, Yan JH, Tang WJ, Shen B, Mo S, Wang Y, Hu DH, Dong ZX, Zhang SB. PRMT5 imposed a dual repression on DDIT3 transcription to promote the malignancy of hepatocellular carcinoma. World J Gastroenterol 2026; 32(19): 115332
- URL: https://www.wjgnet.com/1007-9327/full/v32/i19/115332.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i19.115332